About Conference
OMICS International is pleased to organize 2nd International Conferfence on Therapeutic Drug Moitoring and Toxicogenomics during August 25-26, 2016 at Philadelphia, USA.The Conference mainly focuses on the theme "Discoveries and Developments for Safer Medication".It is an extraordinary event designed for the professionals to facilitate the dissemination and application of research finding on Drug Monitoring and Toxicogenomics.
Drug Monitoring 2016 is a multidisciplinary approach. Drug concentration measurements are requested to assist the management of a patient's current medication regimen or to screen for a medicine. The Drug Monitoring studies are performed for monitoring drugs with narrow therapeutic ranges, drugs with marked pharmacokinetic variability, medications for which target concentrations are difficult to monitor, and drugs known to cause therapeutic and adverse effects. The process of TDM is predicated on the assumption that there is a definable relationship between dose and plasma or blood drug concentration, and between concentration and therapeutic effects. Accurate and clinically meaningful drug concentrations are attainable only by complete collaboration by a TDM team, typically comprised of scientists, clinicians, nurses, and pharmacists. OMICS International organizes a conference series of 3000+ Global Events inclusive of 300+ Conferences, 600+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.
Why to Attend??
Drug Monitoring 2016 gives you access to leading-edge pharmaceutical information and valuable new professional contact from all over the world. Its large international participation provides excellent opportunities for global sharing of technology, expertise, products, and best practices. There are exhibitions which run in parallel with the conference and offer you the chance to get up-to-date information from companies active in your area of interests. We are grateful to our sponsors and exhibitors for their interest and support for the conference.
Target Audience:
- Professors, Associate Professors, Assistant Professors
- PhD Scholars
- Graduates and Post Graduates
- Directors, CEO’s of Organizations
- Association, Association presidents and professionals
- Noble laureates in Health Care and Medicine
- Pharmacists
- Toxicology Professionals
- Genetic Professionals
- Bio instruments Professionals
- Bio-informatics Professionals
- Software development companies
- Research Institutes and members
- Supply Chain companies
- Manufacturing Companies
- Training Institutes
- Business Entrepreneur
Conference Highlights
- Drug Monitoring
- Pharmacokinetics & Pharmacodynamics
- Gender & Pathophysiology
- Individual Drugs TDM
- Drug Quantification
- TDM Challenges
- Advances in TDM
- Toxicogenomics Roles
- OMICS Technologies
- Adverse Outcome Pathways
- Environmental Toxicogenomics
- Comparative Toxicogenomics
- Toxicogenomics Challenges
- Toxicogenomics Applications
Special Issues
- All accepted abstracts will be published in respective OMICS International Journals.
- Abstracts will be provided with Digital Object Identifier by Cross Ref.
See more at: http://toxicogenomics.conferenceseries.com/
